Sponsored by

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 3226 to 3250 of about 5895

Previous 25

Website Changes

06/01/2009

Drug Made From Cottonseed May Slow Brain Cancer, Researchers Say

06/01/2009

Most common brain cancer may originate in neural stem cells

06/01/2009

Pfizer and Celldex Therapeutics Present Update on CDX-110 (PF-04948568) Phase 2 Brain Cancer Studies at 45th Annual ASCO Meeting

06/01/2009

Added a few videos to the video library.. More will be added soon!

06/01/2009

Updated survivor story Tom K

05/28/2009

Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program

05/28/2009

Common Cancer Drug (Avastin) May Increase Risk of Deadly GI Perforations

05/27/2009

Amber Alert: Pennsylvania

05/26/2009

Call for support: Senator Kennedy`s Cancer Bill (S. 717 called 21st Century Cancer ALERT-

05/25/2009

Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery

05/25/2009

Brain Tumor Talk Radio

05/24/2009

IBTA E-News May 24 2009

05/22/2009

Retrospective analysis of outcomes among more than 1,000 patients with newly diagnosed anaplastic oligodendroglial tumors.

05/14/2009

Very late relapses in glioblastoma long-term survivors.

05/14/2009

05/14/2009

ASCO Abstracts now available online!

05/14/2009

A phase II study of chemoradiation followed by adjuvant temozolomide and poly-ICLC in patients with newly diagnosed glioblastoma: 12- and 18-month survival data (NABTT 0501).

05/14/2009

Bevacizumab in combination with radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma: Update progression-free survival, overall survival, and toxicity.

05/14/2009

Epidermal growth factor receptor variant III (EGFRvIII) vaccine (CDX-110) in GBM.

05/14/2009

Targeting brain tumor stem cells using a bispecific antibody directed against CD133+ and EGFRvIII+.

05/14/2009

A phase I trial of tumor-associated antigen-pulsed dendritic cell immunotherapy for patients with brain stem glioma and glioblastoma.

05/14/2009

A phase I trial of surgical resection with biodegradable carmustine (BCNU) wafer placement followed by vaccination with dendritic cells pulsed with tumor lysate for patients with malignant glioma.

05/14/2009

A phase I evaluation of intravenous TM601 in recurrent glioblastoma: Use of perfusion MRI to monitor antiangiogenic effects.

05/14/2009

05/14/2009

The Role of Supplements (including Anti-Oxidants) in Cancer Treatment

Our privacy / cookie policy has changed.
Click HERE to read it!